A major healthcare company has finalized a $194 million sustainability-focused loan agreement with Singapore’s largest banking institution, linking portions of the financing to enhanced antibiotic management practices across multiple medical facilities.
IHH Healthcare announced Friday that it completed the S$250 million loan arrangement with DBS, which establishes performance benchmarks for four Singapore medical centers: Mount Elizabeth, Mount Elizabeth Novena, Gleneagles and Parkway East hospitals.
Under the agreement’s terms, these medical facilities must enhance their monitoring procedures to evaluate whether patients require continued antibiotic therapy within 72 hours of beginning treatment.
Both organizations stated that the initiative aims to reduce inappropriate antibiotic usage, which contributes to the development of drug-resistant bacterial strains and creates more challenging treatment scenarios for infections.
IHH Healthcare noted that this program aligns with Singapore’s broader national strategy to combat antimicrobial resistance.
